Thyrotropin-releasing hormone (TRH) The tripeptide thyrotropin-releasing hormone (TRH; thyroliberin), pGlu-His-ProNH2, is secreted from the hypothalamus into the hypothalamic-pituitary portal system. At the anterior. pituitary, TRH simulates the release of both thyrotropin and prolactin (1-3). In GH4C1 cells, a clonal line of rat pituitary tumor cells, TRH increases the synthesis and release of prolactin (4). The effects of TRH on normal pituitaries and GH4C1 cells are thought to be initiated by association ofTRH with a specific cell surface receptor, which has been identified in both systems (5-7).
parentK of400 nM. Binding ofFL-TRH to unfixed, viable GH4CI cells was followed by fluorescence microscopy. After incubation with 1.4 FAM FL-TRH for 1 hr at 370C, the surface of all cells was fluorescent and patches of intense fluorescence were evident. Control cultures incubated with FL-TRH and excess TRH were not fluorescent, and a line ofpituitary tumor cells which lacks TRH receptors displayed little fluorescence after incubation with FL-TRH. When GH4C1 cells were incubated with FL-TRH for 1 hr at 37°C and then with excess TRH for an additional 1 hr, the fluorescence associated with the cells was diminished to control levels. The results demonstrate that the fluorescein-labeled peptide labels specific TRH receptors.
The tripeptide thyrotropin-releasing hormone (TRH; thyroliberin), pGlu-His-ProNH2, is secreted from the hypothalamus into the hypothalamic-pituitary portal system. At the anterior. pituitary, TRH simulates the release of both thyrotropin and prolactin (1) (2) (3) . In GH4C1 cells, a clonal line of rat pituitary tumor cells, TRH increases the synthesis and release of prolactin (4) . The effects of TRH on normal pituitaries and GH4C1 cells are thought to be initiated by association ofTRH with a specific cell surface receptor, which has been identified in both systems (5) (6) (7) .
[3H]TRH binds rapidly to receptors on GH4C1 cells with noncooperative kinetics; the apparent Kd is 10 nM and the average number of sites per cell is approximately 100,000 (6, 8) . There is a strong correlation between the biological activity of TRH analogs (measured as ability to stimulate prolactin synthesis) and the affinity for TRH receptors (9) .
Peptide hormones are generally thought to bind initially to receptors on the plasma membrane, but the location ofTRH receptors is uncertain. In broken cell preparations [3H]TRH binds to fractions containing plasma membranes but also to nuclei and smooth microsomes (10) . There is little or no binding to soluble components (11) . Isolated cell nuclei have also been reported to bind [3H]TRH (12) . In order to investigate early events in TRH action, we have synthesized a fluorescein-labeled derivative of TRH (FL-TRH) and used it to visualize binding to TRH receptors in living GH4C1 cells.
MATERIALS AND METHODS
Unlabeled TRH and pGlu-His-ProNH(CH2)6NH2 were generous gifts from Abbott. [3H]TRH (100 Ci/mmol; 1 Ci = 3.7 X 1010 becquerels) was purchased from New England Nuclear, and fluorescein isothiocyanate (isomer I) was from Sigma. Tissue culture media and normal sera were from GIBCO, and thyroid hormone-deficient serum was obtained from a surgically thyroidectomized young steer.
Pituitary cell lines were grown as described (13) (6) . Nonspecific binding was determined in control reactions containing excess unlabeled TRH; nonspecific binding was less than 5% of total binding to GH4C1 cells and has been subtracted.
For use in microscopy, cells were grown on glass cover slips. The cover slips were rinsed in serum-free Ham's F10 medium and then incubated in serum-free medium containing FL-TRH and TRH, as indicated in the text, at 370C for 1-2 hr. The cover slips were gently rinsed in ice-cold 0.15 M NaCl, inverted onto slides, and viewed immediately in a Zeiss Photomicroscope III with epifluorescence. In all experiments the exposure conditions, development, and printing vere identical for control and experimental cells.
RESULTS
Synthesis of a Fluorescent Analog. FL-TRH was synthesized by coupling pGlu-His-ProNH(CH2)6NH2 to fluorescein isothiocyanate by standard procedures (14) . [The peptide used for coupling is active in stimulating the release and synthesis of prolactin by pituitary tumor cells (15) . ] One milligram of pGluHis-ProNH(CH2)6NH2 was treated with 5 mg offluorescein isothiocyanate for 18 hr at 40C in NaHCO3 / Na2CO3 buffer at pH 7.0. The coupled product was separated from unreacted starting materials by filtration through Sephadex G-10 followed by chromatography on DEAE-cellulose. FL-TRH did not appear to be contaminated with any Pauly-positive or fluorescent material as judged by thin-layer chromatography in several systems. The overall yield was 80%. The concentration ofFL-TRH was determined spectrophotometrically at 495 nm using e = 7.4 X 104
Abbreviations: TRH, thyrotropin-releasing hormone (thyroliberin); FL-TRH, fluorescein-labeled analog ofthyrotropin-releasing hormone.
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The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. M-' cm-'. The structure of FL-TRH is shown in Fig. 1 (Fig. 3 C and D) hypothyroid medium was Ham's F10 supplemented with 10% serum from a thyroidectomized calf (this serum contained undetectable levels ofthyroxine and L-triiodothyronine). The cells were then incubated with FL-TRH and used for fluorescence microscopy as described in Fig. 3 A and B . In both sets of cultures, 100% ofthe cells were fluorescent.
DISCUSSION
The results of this study show that specific binding of FL-TRH to TRH receptors can be observed by fluorescence microscopy on unfixed, viable cells. Biological responses to TRH (stimulation of prolactin release and uridine uptake) have been demon- (6, 8) . Some peptide hormones that bind to cell surface receptors, such as insulin and epidermal growth factor, are rapidly internalized and degraded under conditions similar to those used in our experiments (17) (18) (19) . In contrast, a fluorescently labeled opiate receptor agonist, rhodamine-enkephalin, was observed in clusters but did not internalize in several hours (20) .
The results with FL-TRH resemble those obtained with rhodamine-enkephalin. The TRH-receptor complex seems to internalize and become inactivated over 24-48 hr, as evidenced by the appearance of TRH metabolites in the cell (21) and "downregulation" ofTRH receptors (22) 
